We are live on ! Find out more
ACOR

Acorda Therapeutics
ACOR

Delisted

ACOR was delisted on the 11th of April, 2024.

Back to rankings

175 hedge funds and large institutions have $899M invested in Acorda Therapeutics in 2016 Q4 according to their latest regulatory filings, with 28 funds opening new positions, 59 increasing their positions, 57 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

56% more first-time investments, than exits

New positions opened: 28 | Existing positions closed: 18

5% more funds holding

Funds holding: 167 → 175 (+8)

4% more repeat investments, than reductions

Existing positions increased: 59 | Existing positions reduced: 57

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

11% less capital invested

Capital invested by funds: $1.01B → $899M (-$108M)

83% less call options, than puts

Call options by funds: $7.01M | Put options by funds: $40.8M

Holders
175
Holders Change
+8
Holders Change %
+4.79%
% of All Funds
4.38%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
28
Increased
59
Reduced
57
Closed
18
Calls
$7.01M
Puts
$40.8M
Net Calls
-$33.8M
Net Calls Change
-$26.8M

Top Buyers

Rank Fund Capital Flow
1
PA
Perceptive Advisors
New York
+$14.3M
2
BFA
BlackRock Fund Advisors
California
+$12.4M
3
SCM
Scopia Capital Management
New York
+$6.5M
4
SM
Sabby Management
Florida
+$5.23M
5
Millennium Management
Millennium Management
New York
+$4.83M

Top Sellers

Rank Fund Capital Flow
1
EAM
Eagle Asset Management
Florida
-$13.7M
2
Citadel Advisors
Citadel Advisors
Florida
-$10.8M
3
Wellington Management Group
Wellington Management Group
Massachusetts
-$8.44M
4
Goldman Sachs
Goldman Sachs
New York
-$7.54M
5
Westfield Capital Management
Westfield Capital Management
Massachusetts
-$7.43M
Name Holding Trade Value Shares
Change 		Change in
Stake
QT
126
Quantbot Technologies
New York
$274K -$33.3K -14 -10%
VKH
127
Virtu KCG Holdings
New York
$272K +$285K +120 New
PAM
128
Panagora Asset Management
Massachusetts
$267K -$1.06M -446 -79%
PA
129
Profund Advisors
Maryland
$265K +$281K +118 New
DTL
130
Dynamic Technology Lab
Singapore
$255K +$269K +113 New
CG
131
Cutler Group
California
$251K +$85.6K +36 +47%
CAM
132
Capstone Asset Management
Texas
$229K -$73.7K -31 -23%
TRSOTSOK
133
Teachers Retirement System of the State of Kentucky
Kentucky
$220K -$243K -102 -51%
MERSOM
134
Municipal Employees' Retirement System of Michigan
Michigan
$198K +$7.13K +3 +4%
BlackRock
135
BlackRock
New York
$194K -$150K -63 -43%
MAM
136
Martingale Asset Management
Massachusetts
$191K -$16.6K -7 -8%
RJA
137
Raymond James & Associates
Florida
$189K -$112K -47 -36%
MSA
138
Mason Street Advisors
Wisconsin
$189K +$11.9K +5 +6%
SAMH
139
Shanda Asset Management Holdings
British Virgin Islands
$188K – – –
BNP Paribas Financial Markets
140
BNP Paribas Financial Markets
France
$188K +$61.8K +26 +46%
CSS
141
Cubist Systematic Strategies
Connecticut
$183K +$47.5K +20 +33%
CIA
142
Capital Impact Advisors
Massachusetts
$169K – – –
TRCT
143
Tower Research Capital (TRC)
New York
$119K +$124K +52 New
PI
144
PineBridge Investments
New York
$111K – – –
SOADOR
145
State of Alaska Department of Revenue
Alaska
$93K +$99.9K +42 New
AIM
146
Acrospire Investment Management
Illinois
$79K +$28.5K +12 +52%
PAM
147
Paradigm Asset Management
New York
$79K -$2.38K -1 -3%
FMT
148
First Mercantile Trust
Tennessee
$65K +$2.38K +1 +4%
Nisa Investment Advisors
149
Nisa Investment Advisors
Missouri
$62K – – –
Zurich Cantonal Bank
150
Zurich Cantonal Bank
Switzerland
$55K +$33.3K +14 +140%
4 5
6
7 8

ACOR Hedge Fund Activity: Q4 2016 in Review

175 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Acorda Therapeutics (ACOR) for Q4 2016, worth a combined $899M — down 11% from $1.01B a quarter earlier.

Buyers outnumbered sellers: 28 funds opened new ACOR positions and 18 closed out — a net gain of 10 holders — while 59 added to existing stakes and 57 trimmed.

The largest buyer was Perceptive Advisors, opening a new position worth an estimated $14.3M. The largest seller was Eagle Asset Management, cutting an estimated $13.7M.

  • 175 institutional investors held Acorda Therapeutics (ACOR) as of Q4 2016, up from 167 in Q3 2016.
  • Funds reported $899M of Acorda Therapeutics stock for Q4 2016, down 11% quarter-over-quarter.
  • 28 funds opened new Acorda Therapeutics positions in Q4 2016 and 18 closed out, a net change of +10 holders.
  • The largest Acorda Therapeutics buyer in Q4 2016 was Perceptive Advisors, an estimated $14.3M added.
  • The largest Acorda Therapeutics seller in Q4 2016 was Eagle Asset Management, an estimated $13.7M sold.

Based on aggregated 13F filings for Q4 2016.